Related Experiment Video

Updated: Oct 10, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Clinical trials referral resource. Current clinical trials for the proteasome inhibitor PS-341

J Wright, V L Hillsamer, R E Gore-Langton

    Oncology (Williston Park, N.Y.)
    |December 29, 2000
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
    08:29

    Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

    Published on: October 2, 2014

    Related Experiment Videos

    Last Updated: Oct 10, 2026

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
    00:04

    A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

    Published on: September 20, 2019

    Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
    08:29

    Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics

    Published on: October 2, 2014

    Related Concept Videos

    The Proteasome01:13

    The Proteasome

    Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
    In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

    Articles linked to this work by shared authors, journal, and citation graph.

    A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).

    Annals of oncology : official journal of the European Society for Medical Oncology·2017

    Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017

    Current Status of U.S. Clinical Trials in Chronic Lymphocytic Leukemia.

    Leukemia & lymphoma·2016

    Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes.

    Leukemia·2015

    Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma.

    Blood cancer journal·2014

    How we manage follicular lymphoma.

    Leukemia·2014

    Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.

    Oncology (Williston Park, N.Y.)·2026

    Homologous Recombination and Mismatch Repair Assessment in Men With Advanced Prostate Cancer: A Cross-Sectional Study From a Center in Mexico City.

    Oncology (Williston Park, N.Y.)·2026

    Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.

    Oncology (Williston Park, N.Y.)·2026

    Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.

    Oncology (Williston Park, N.Y.)·2026

    Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.

    Oncology (Williston Park, N.Y.)·2026

    Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

    Oncology (Williston Park, N.Y.)·2026

    Mapping PANSS factor dynamics: a novel framework for tracking therapeutic response in schizophrenia.

    Frontiers in psychiatry·2026

    Effectiveness and safety of tenecteplase for acute ischaemic stroke at primary stroke centres: a multicentre retrospective study.

    Stroke and vascular neurology·2026

    Treatment Fidelity in a Multi-Centre Study of Early Physical Rehabilitation in Mechanically Ventilated Patients: A Secondary Analysis of the CYCLE Pilot RCT.

    Physiotherapy Canada. Physiotherapie Canada·2026

    What is clinically significant improvement in cognitive behavioral therapy for insomnia? A scoping review of randomized controlled trials.

    Sleep medicine reviews·2026

    The effects of a multimodal intervention for optimising sleep and internalising symptoms in young adults during British Army Infantry Basic Training.

    Sleep·2026

    Rectal Insertion of Foreign Bodies: Motivations, Complications, and Management.

    The primary care companion for CNS disorders·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us